Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

National Institutes of Child Health and Human Development / A multi-center, randomized study of the efficacy of ulipristal acetate (UPA) 30 mg, levonorgestrel (LNG) 1.5 mg, and LNG 3.0 mg for emergency contraception (EC) in women with weight 80 kg
A Study of Emergency Contraception in Women with Weight Greater Than or Equal To 176 lbs.
Sponsor:The National Institutes of Health NIH - National Institutes of Child Health and Human Development
Enrolling:Female Patients Only
Study Length:1 Months
Clinic Visits:1
Age Range:Between 18 and 40 years old
IRB Number:AAAR8722
U.S. Government ID:NCT03537768
Contact: Yessica Estrella Vanterpool: (212) 305-8031 / ye2193@cumc.columbia.edu
Additional Study Information:

Did you have unprotected sex? Do you weigh at least 176 pounds? This clinical trial is an experimental research study using a new dose of emergency contraception or morning-after pill. You may qualify if you: Are a premenopausal, healthy woman between the ages of 18 and 40. Weigh more than 176 pounds. Have an intact uterus with at least one ovary. Have regular menstrual cycles. If you qualify, you will: Receive a free investigational emergency contraceptive pill. Comply with protocol requirements, including taking an oral medication. Attend approximately 2 clinic visits and receive follow up phone calls over approximately one month. Receive financial compensation for completing the study.

Do You Qualify?
Are you a female between the ages of 18 and 40 years old?YesNo
Have you had contraception failure in the last 72 hours?YesNo
Do you weigh 176lbs or more?YesNo
Submit
Cancel
Investigator
Carolyn Westhoff, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Yessica Estrella Vanterpool
Email: ye2193@cumc.columbia.edu
Phone: (212) 305-8031